![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ADVANCED NEUROMODULATION SYSTEMS RECEIVES AUSTRALIAN REGULATORY AND REIMBURSEMENT APPROVAL FOR RECHARGEABLE CHRONIC PAIN SYSTEM
ADVANCED NEUROMODULATION SYSTEMS RECEIVES AUSTRALIAN REGULATORY AND REIMBURSEMENT APPROVAL FOR RECHARGEABLE CHRONIC PAIN SYSTEM
Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc., announced Australian Therapeutic Goods Administration (TGA) regulatory approval for its Eon Rechargeable Neurostimulation System. In Australia, the Eon system is fully reimbursable via the private health system.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20061003005122&newsLang=en)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct